(Q47561355)

4 February 2018

title

Influence of IL28B and MxA gene polymorphisms on HCV clearance in Han Chinese population (English)

1 reference

4 February 2018

Corrigendum: Influence of IL28B and MxA gene polymorphisms on HCV clearance in Han Chinese population.

corrigendum / erratum

0 references

author name string

Feng Zang

1

1 reference

4 February 2018

Ming Yue

2

1 reference

4 February 2018

Yinan Yao

3

1 reference

4 February 2018

Mei Liu

4

1 reference

4 February 2018

Haozhi Fan

5

1 reference

4 February 2018

Yue Feng

6

1 reference

4 February 2018

Xueshan Xia

7

1 reference

4 February 2018

Peng Huang

8

1 reference

4 February 2018

Rongbin Yu

9

1 reference

4 February 2018

publication date

22 December 2017

1 reference

4 February 2018

Epidemiology and Infection

published in

1 reference

4 February 2018

page(s)

1-7

1 reference

4 February 2018

A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0950268817002928

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268817002928

Role of IL28B genotype in the liver stiffness increase in untreated patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268817002928

Hepatitis B Virus Reactivation Associated With Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus: A Review of Cases Reported to the U.S. Food and Drug Administration Adverse Event Reporting System

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268817002928

Safety and efficacy of sofosbuvir-based direct-acting antiviral regimens for hepatitis C virus genotypes 1-4 and 6 in Myanmar: Real-world experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268817002928

Daclatasvir plus sofosbuvir, with or without ribavirin, achieved high sustained virological response rates in patients with HCV infection and advanced liver disease in a real-world cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268817002928

Extrahepatic manifestations of HCV: the role of direct acting antivirals

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268817002928

Impact of IL28B and OAS gene family polymorphisms on interferon treatment response in Caucasian children chronically infected with hepatitis B virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268817002928

IL28B rs12980275 variant as a predictor of sustained virologic response to pegylated-interferon and ribavirin in chronic hepatitis C patients: A systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268817002928

A novel polymorphism near HLA class II region is associated with spontaneous clearance of HCV and response to interferon treatment in Chinese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268817002928

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268817002928

APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268817002928

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268817002928

Genetic variation in IL28RA is associated with the outcomes of HCV infection in a high-risk Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268817002928

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268817002928

IL28B CC genotype: a protective factor and predictor of the response to interferon treatment in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268817002928

Identification of a single nucleotide polymorphism in the MxA gene promoter (G/T at nt -88) correlated with the response of hepatitis C patients to interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268817002928

Nomenclature and numbering of the hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268817002928

Global epidemiology of HCV subtypes and resistance-associated substitutions evaluated by sequencing-based subtype analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268817002928

IL28B polymorphism associated with spontaneous clearance of hepatitis C infection in a Southern Brazilian HIV type 1 population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268817002928

Expression and gene polymorphisms of interleukin 28B and hepatitis B virus infection in a Chinese Han population

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268817002928

IL-28B polymorphisms correlated with treatment response in HCV-4 mono-infected patients: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268817002928

Gene polymorphisms of IL-10 and MxA in responders and non-responders to interferon therapy in HCV Egyptian patients genotype 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268817002928

IFNL3/4 genotype is associated with altered immune cell populations in peripheral blood in chronic hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268817002928

IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268817002928

Vitamin D level and vitamin D receptor genetic variations contribute to HCV infection susceptibility and chronicity in a Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268817002928

Infection control guidelines for prevention of health care-associated transmission of hepatitis B and C viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268817002928

10.1017/S0950268817002928

21 January 2018

Identifiers

DOI

1 reference

4 February 2018

1 reference

4 February 2018